CECILIA BARDY-GAGNER: Open Payments
NPI 1770217804 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 22 payments from 9 companies in 2025. Trend: 2023 $1,021 · 2024 $841 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $11 |
Products named: SKYRIZI, RINVOQ, ENTYVIO, MAVYRET, IQIRVO, CREON, IBSRELA, TREMFYA.
Industry payments across VA — which companies pay providers there.
